Drug-induced linear IgA bullous dermatosis

Journal of Dermatology

Volumn 32, Issue 9, 2005, Pages 759-764

  Onodera, Hanae ^a,b,c   Mihm Jr , Martin C ^a   Yoshida, Aki ^b   Akasaka, Toshihide ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

Drug induced; Linear IgA bullous dermatosis; Vancomycin

Indexed keywords

AMIODARONE; AMPICILLIN; ATORVASTATIN; BENAZEPRIL; CAPTOPRIL; CARBAMAZEPINE; CEFAMANDOLE; CEFTRIAXONE; CYCLOSPORIN; DICLOFENAC; FUROSEMIDE; GAMMA INTERFERON; GLIBENCLAMIDE; HYPOCHLORITE SODIUM; IMMUNOGLOBULIN A; INTERLEUKIN 2; IODINE; LITHIUM CARBONATE; METRONIDAZOLE; NAPROXEN; PARACETAMOL; PENICILLIN G; PHENYTOIN; PIROXICAM; RIFAMPICIN; SOMATOSTATIN; SULFAFURAZOLE; UNINDEXED DRUG; VANCOMYCIN; VIGABATRIN;

AGED; ANAMNESIS; ARTICLE; AUTOIMMUNE DISEASE; BACTERIAL ENDOCARDITIS; BLISTER; BULLOUS SKIN DISEASE; CASE REPORT; CELL INFILTRATION; CHEEK MUCOSA; CLINICAL FEATURE; DISEASE COURSE; DRUG INDUCED DISEASE; EPIDERMIS; ERYTHEMA; FEMALE; HUMAN; IMMUNOFLUORESCENCE; INFLAMMATORY CELL; JAPAN; LABORATORY TEST; PEMPHIGOID;

EID: 26644467232     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2005.tb00839.x     Document Type: Article

References (51)

1. Avci O, Okmen M, Cetiner S: Acetaminophen-induced linear IgA bullous dermatosis, J Am Acad Dermatol, 48: 299-300, 2003.
2. Bachot N, Wechsler J, Demoule A, Roujeau J-C: Amiodarone-related linear IgA bullous dermatosis, J Am Acad Dermatol, 49: E11-12, 2003.
3. Romano A, Quaratino D, Di Fonso M, Papa G, Venuti A, Gasbarrini G: A diagnostic protocol for evaluating nonimmediate reactions to aminopenicillins, J Allergy Clin Immunol, 103: 1186-1190, 1999.
4. Konig C, Eickert A, Scharfetter-Kochanek K, Krieg T, Hunzelmann N: Linear IgA bullous dermatosis induced by atorvastatin, J Am Acad Dermatol, 44: 689-692, 2001.
5. Femiano F, Scully C, Gombos F: Linear IgA dermatosis induced by a new angiotensin-converting enzyme inhibitor, Oral Surg Oral Med Oral Pathol Radiol Endod, 95: 169-173, 2003.
6. Pena-Penabad C, Rodriguez-Lozano J, del Pozo J, Garcia-Silva J, Fonseca E: Linear IgA bullous dermatosis induced by angiotensin receptor antagonists, Am J Med, 114: 163-164, 2003.
7. Friedman IS, Rudikoff D, Phelps RG, Sapadin AN: Captopril-triggered linear IgA bullous dermatosis, Int J Dermatol, 37: 600-612, 1998.
8. Cohen LM, Ugent RB: Linear IgA bullous dermatosis occurring after carbamazepine, J Am Acd Dermatol, 46: S32-33, 2002.
9. Yawalker N, Reimers A, Hari Y, et al: Drug-induced linear IgA bullous dermatosis associated with ceftriaxone- and metronidazole-specific T cells, Dermatology, 199: 25-30, 1999.
10. Argenyi ZB, Bergfeld WF, Valenzuela R, McMahon JT, Taylor JS: Adult linear IgA disease associated with an erythema multiforme-like drug reaction, Cleve Clin J Med, 54: 445-450, 1987.
11. Petit D, Borradori L, Rybojad M, Morel P: Linear IgA bullous dermatosis after heart transplantation, J Am Acad Dermatol, 22: 851, 1990.
12. Cerottini J-P, Ricci C, Guggisberg D, Panizzon RG: Drug-induced linear IgA bullous dermatosis probably induced by furosemide, J Am Acad Dermatol, 41: 103-105, 1999.
13. del Pozo J, Martinez W, Yebra-Pimentel MT, Almagro M, Pena-Penabad C, Fonseca E: Linear immunoglobulin A bullous dermatosis induced by gemcitabin, Ann Pharmacother, 35: 891-893, 2001.
14. Väätäinen N, Fräki JE, Hyvönen M, Neittaanmäki H: Purpura with a linear epidermo-dermal deposition of IgA, Acta Derm Vennerol, 63: 169-170, 1983.
15. Kano Y, Kokaji T, Shiohara T: Linear IgA bullous dermatosis in a patient with acute lymphocytic leukemia: possible involvement of granulocyte colony-stimulating factor, Eur J Dermatol, 9: 122-125, 1999.
16. Tranvan A, Pezen DS, Medenica M, Michelson GC, Vogelzang N, Soltani KM: Interleukin-2 associated linear IgA bullous dermatosis, J Am Acad Dermatol, 35: 865-867, 1996.
17. Wakelin SH, Wojnarowska F: Linear IgA disease exacerbated by topical iodine preparations, Br J Dermatol, 131: 918, 1994.
18. McWhirter JD, Hashimoto K, Fayne S, Ito K: Linear IgA bullous dermatosis related to lithium carbonate, Arch Dermatol, 123: 1120-1122, 1987.
19. Bouldin MB, Clowers-Webb HE, Davis JL, McEvoy MT, Davis MDP: Naproxen-associated linear IgA bullous dermatosis: case report and review, Mayo Clin Proc, 75: 967-970, 2000.
20. Tran D, Kossard S, Shumack S: Phenytoin-induced linear IgA dermatosis mimicking toxic epidermal necrolysis, Aus J Dermatol, 44: 284-286, 2003.
21. Plunkett RW, Chiarello SE, Beutner EH: Linear IgA bullous dermatosis in one of two piroxicam-induced eruptions: A distinct direct immunofluorescence trend revealed by the literature, J Am Acad Dermatol, 45: 691-696, 2001.
22. Pellicano R, Lomuto M, Cozzani E, Iannantuono M, De Simone C: Linear IgA bullous dermatosis after contact with sodium hypochlorite, Dermatology, 194: 284-286, 1997.
23. Tonev S, Vasileva S, Kadurina M: Depot sulfonamid associated linear IgA bullous dermatosis with erythema multiforme-like clinical features, J Eur Acad Dermatol Venereol, 11: 165-168, 1998.
24. Geissmann C, Beylot-Barry M, Doutre M-S, Beylot C: Drug-induced linear IgA bullous dermatosis, J Am Acad Dermatol, 32: 296, 1995.
25. Kuechle MK, Stegemeir E, Maynard B, Gibson LE, Leiferman KM, Peters MS: Drug-induced linear IgA bullous dermatosis: Report of six cases and review of the literature, J Am Acad Dermatol, 30: 187-192, 1994.
26. Nousari HC, Costarangos C, Anhalt GJ: Vancomycin-associated linear IgA bullous dermatosis, Ann Intern Med, 129: 507-508, 1998.
27. Neughebauer BI, Negron G, Pelton S, Plunkett RW, Beutner EH, Magnussen R: Bullous skin disease: An unusual allergic reaction to vancomycin, Am J Med Sci, 323: 273-278, 2002.
28. Dellavalle RP, Burch JM, Tayal S, Golitz LE, Fitzpatrick JE, Walsh P: Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis, J Am Acad Dermatol, 48: S56-57, 2003.
29. Whitworth JM, Thomas I, Peltz SA, Sullivan BC, Wolf AH, Cytryn AS: Vancomycin-induced linear IgA bullous dermatosis (LABD), J Am Acad Dermatol, 34: 890-891, 1996.
30. Klein PA, Callen JP: Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency, J Am Acad Dermatol, 42: 316-323, 2000.
31. Paul C, Wolkenstein P, Prost C, et al: Drug-induced Linear IgA disease: target antigens are heterogenous, Br J Dermatol, 136: 406-411, 1997.
32. Wakelin SH, Allen J, Zhou S, Wojnarowska F: Drug-induced linear IgA disease with antibodies to collagen VII, Br J Dermatol, 138: 310-314, 1998.
33. Palmer RA, Ogg G, Allen J, et al: Vancomycin-induced linear IgA disease with autoantibodies to BP180 and LAD285, Br J Dermatol, 145: 816-820, 2001.
34. Barnadas MA, Moreno A, Brunet S, et al: Linear IgA bullous dermatosis associated with Hodgkin's disease, J Am Acad Dermatol, 19: 1122-1124, 1988.
35. Hollo P, Preisz K, Nemes L, Biro J, Karpati S, Horvath A: Linear IgA dermatosis associated with chronic clonal myeloproliferative disease, Int J Dermatol, 42: 143-146, 2003.
36. Hayakawa K, Shiohara T, Yagita A, Nagashima M: Linear IgA bullous dermatosis associated with rheumatoid arthritis, J Am Acad Dermatol, 26: 110-113, 1992.
37. Lau M, Kaufmann-Grunzinger I, Raghunath M: A case report of a patient with features of systemic lupus erythematosus and linear IgA disease, Br J Dermatol, 124: 498-502, 1991.
38. Barrows-Wade L, Jordon RE, Arnett FC: Linear IgA bullous dermatosis associated with dermatomyositis, Arch Dermatol, 128: 413-414, 1992.
39. van der Wall RIF, van de Scheur MR, Pas HH, et al: Linear IgA bullous dermatosis in a patient with renal cell carcinoma, Br J Dermatol, 144: 870-873, 2001.
40. Rodenas JM, Herranz MT, Tercedor J, Concha A: Linear IgA disease in a patient with bladder carcinoma, Br J Dermatol, 136: 257-259, 1997.
41. Chi H-I, Arai M: Linear IgA bullous dermatosis associated with ulcerative colitis, J Dermatol, 26: 150-153, 1999.
42. Blickenstaff RD, Perry HO, Peters MS: Linear IgA deposition associated with cutaneous varicella-zoster infection: a case report, J Cutan Pathol, 15: 49-52, 1988.
43. Girao L, Fradeiro T, Rodrigues JC: Burn-induced linear IgA dermatosis, J Eur Acad Dermatol Venereol, 14: 507-510, 2000.
44. Perrett CM, Evans AV, Russell-Jones R: Tea tree oil dermatitis associated with linear IgA disease. Clin Exp Dermatol, 28: 167-170, 2003.
45. Salmhofer W, Soyer HP, Wolf P, Fodinger D, Hodl S, Kerl H: UV light-induced linear IgA dermatosis. J Am Acad Dermatol, 50: 109-115, 2004.
46. Kim P-H, Kagnoff MF: Transforming growth factor β1 increases IgA isotype switching at the clonal level, J Immunol, 145: 3773-3778, 1990.
47. Murray PD, McKenzie DT, Swain SL, Kagnoff MF: Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression, J Immunol, 139: 2669-2674, 1987.
48. Beagley KW, Eldridge JH, Lee F, et al: Interleukins and IgA synthesis: human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells, J Exp Med, 169: 2133-2148, 1989.
49. Briere F, Bridon J-M, Chevet D, et al: Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA, J Clin Invest, 94: 97-104, 1994.
50. Allen J, Wojnarowska F: Linear IgA disease: The IgA and IgG response to the epidermal antigens demonstrates that intermolecular epitope spreading is associated with IgA rather than IgG antibodies, and is more common in adults, Br J Dermatol, 149: 977-985, 2003.
51. Fujimoto W, Ohtsu T, Toi Y, Nakanishi G, Arata J: Linear IgA disease with IgA antibodies directed against 200- and 280-kDa epidermal antigens, Br J Dermatol, 142: 1213-1218, 2000.